A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)

The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an

Pingxiang People's Hospital, Pingxiang

Zhuhai People's Hospital, Zhuhai

Peking University People's Hospital, Beijing

Hunan Provincial People's Hospital, Changsha

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

Fujian Medical University Union Hospital, Fujian

Fuyang People's Hospital, Fuyang

Guangdong Provincial People's Hospital, Guangzhou

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

The First Affiliated Hospital, Sun Yat-sen University, Guanzhou

The First Affiliated Hospital, Zhejiang University, Hanzhou

The Second Hospital of Anhui Medical University, Hefei

Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan

Liu Zhou Works Hospital, Liuzhou

The First Affiliated Hospital of Nanchang University, Nanchang

Jiangsu Province Hospital, Nanjing

Zhongda Hospital Southeast University, Nanjing

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

Huashan Hospital Fudan University, Shanghai

Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai

ShengJing Hospital of China Medical University, Shenyang

Shenzhen People's Hospital, Shenzhen

The First Hospital of Hebei Medical University, Shijia Zhuang

The Second Hospital of Tianjin Medical University, Tianjin

Renmin Hospital of Wuhan University, Wuhan

Wuxi People's Hospital, Wuxi

Shaanxi Provincial Hospital of Chinese Medicine, Xi'an

The First Affiliated Hospital of Xiamen University, Xiamen

Xiamen Fifth Hospital, Xiamen

Henan Provincial People's Hospital, Zhengzhou